{"database": "lobbying", "table": "lobbying_activities", "rows": [[3477475, "60151fb0-1a65-4941-b483-33d3b8185259", "Q4", "THE PETRIZZO GROUP, INC.", 305932, "AKEBIA THERAPEUTICS, INC.", 2025, "fourth_quarter", "HCR", "Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2025-12-31T10:35:49-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3477475"], "units": {}, "query_ms": 19.60131898522377, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}